Live from the NIH registry
Studies recruiting near Fort Collins right now
Top 25 of 151 recruiting studies, sorted by proximity — each links to its official registry page
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Generalized Myasthenia Gravis
Phase 3
Interventional 231 participants sought
Site Number - 1027 — Fort Collins, Colorado (2.8 mi)
· Sponsor: Immunovant Sciences GmbH
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Rocky Mountain Cancer Centers LLP — Longmont, Colorado (26.4 mi)
· Sponsor: Pfizer
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer, Pancreatic Cancer Metastatic
Phase 3
Interventional 570 participants sought
Poudre Valley Health Care, Inc — Fort Collins, Colorado (2.8 mi)
· Sponsor: Immuneering Corporation
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Primary Sjogren's Disease
Phase 3
Interventional 250 participants sought
Tekton Research — Fort Collins, Colorado (2.8 mi)
· Sponsor: Vor Biopharma
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Multiple Myeloma
Phase 3
Interventional 893 participants sought
UCHealth Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: Pfizer
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Longmont United Hospital — Longmont, Colorado (26.4 mi)
· Sponsor: NRG Oncology
Health Without Barriers/Salud Sin Barreras
Mental Health Wellness, Family Research
N/A
Interventional 175 participants sought
Colorado State University — Fort Collins, Colorado (2.8 mi)
· Sponsor: Colorado State University
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Primary Open Angle Glaucoma
Phase 3
Interventional 130 participants sought
Eye Center of Northern Colorado /ID# 281798 — Fort Collins, Colorado (2.8 mi)
· Sponsor: AbbVie
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
Advanced Neurosciences Research — Fort Collins, Colorado (2.8 mi)
· Sponsor: TriGemX Bio, Inc.
Improving Care for Rural Patients With Solid Tumors
Lung Cancer, Head and Neck Cancer
N/A
Interventional 320 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: University of Colorado, Denver
Countermeasures to Circadian Misalignment
Circadian Rhythm Sleep Disorder of Shift Work Type, Metabolic Disease
N/A
Interventional 32 participants sought
Colorado State University — Fort Collins, Colorado (2.8 mi)
· Sponsor: Colorado State University
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: National Cancer Institute (NCI)
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 3
Interventional 382 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Multiple conditions
Phase 2
Interventional 314 participants sought
Longmont United Hospital — Longmont, Colorado (26.4 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2, Phase 3
Interventional 131 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: National Cancer Institute (NCI)
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: Canadian Cancer Trials Group
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Rocky Mountain Cancer Centers, LLP — Longmont, Colorado (26.4 mi)
· Sponsor: Relay Therapeutics, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: SWOG Cancer Research Network
Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)
Cannabis Use, Alcohol Use, Unspecified
N/A
Interventional 99 participants sought
Colorado State University — Fort Collins, Colorado (2.8 mi)
· Sponsor: Colorado State University
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
Primary Sjögren's Syndrome
Phase 2
Interventional 180 participants sought
Site Number - 1014 — Fort Collins, Colorado (2.8 mi)
· Sponsor: Immunovant Sciences GmbH
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase 3
Interventional 680 participants sought
Rocky Mountain Cancer Centers LLP — Longmont, Colorado (26.4 mi)
· Sponsor: Pfizer
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Banner North Colorado Medical Center - Loveland Campus — Loveland, Colorado (10.4 mi)
· Sponsor: National Cancer Institute (NCI)
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Emphysema, Pulmonary, Emphysema or COPD
N/A
Interventional 200 participants sought
UCHealth - Medical Center of the Rockies — Loveland, Colorado (10.4 mi)
· Sponsor: Pulmonx Corporation